2003 Wolff Award: Possible Parasympathetic Contributions to Peripheral and Central Sensitization During Migraine
David Yarnitsky MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorItay Goor-Aryeh MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorZahid H. Bajwa MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorBernard I. Ransil PhD, MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorF. Michael Cutrer MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorAnna Sottile MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorRami Burstein PhD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorDavid Yarnitsky MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorItay Goor-Aryeh MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorZahid H. Bajwa MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorBernard I. Ransil PhD, MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorF. Michael Cutrer MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorAnna Sottile MD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorRami Burstein PhD
Departments of Anesthesia and Critical Care (Drs. Yarnitsky, Goor-Aryeh, Bajwa, Sottile, and Burstein) and Neurology (Drs. Yarnitsky, Bajwa, and Ransil), Beth Israel Deaconess Medical Center; the Department of Neurology, Massachusetts General Hospital (Dr. Cutrer); the Department of Neurobiology and the Program in Neuroscience, Harvard Medical School (Dr. Burstein), Boston, Mass. Dr. Yarnitsky's permanent address is the Department of Neurology, Rambam Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Search for more papers by this authorAbstract
Background.—Neurologic signs of increased parasympathetic outflow to the head often accompany migraine attacks. Because increased parasympathetic outflow to the cranial cavity induces vasodilation of cerebral and meningeal blood vessels, it can enhance plasma protein extravasation and the release of proinflammatory mediators that activate perivascular nociceptors. We recently showed that activation of intracranial perivascular nociceptors induces peripheral and central sensitization along the trigeminovascular pathway and proposed that these sensitizations mediate the intracranial hypersensitivity and the cutaneous allodynia of migraine.
Methods.—The present study investigates possible parasympathetic contributions to the generation of peripheral and central sensitization during migraine by applying intranasal lidocaine to reduce cranial parasympathetic outflow through the sphenopalatine ganglion.
Results.—In the absence of migraine, patients were pain-free, and their skin sensitivity was normal. Their mean baseline pain thresholds were less than 15°C for cold, more than 45°C for heat, and more than 100 g for mechanical pressure. Their mean pain score was 7.5 of 10 (standard deviation, 1.4) during untreated migraine and 3.5 of 10 (standard deviation, 2.4) after the nasal lidocaine-induced sphenopalatine ganglion block (P < .0001). Most patients developed cutaneous allodynia during migraine, and their mean pain thresholds changed to more than 25°C for cold, less than 40°C for heat, and less than 10 g for mechanical pressure. Following the nasal lidocaine administration (sphenopalatine ganglion block), this allodynia remained unchanged in spite of the pain relief.
Conclusion.—These findings suggest that cranial parasympathetic outflow contributes to migraine pain by activating or sensitizing (or both) intracranial nociceptors, and that these events induce parasympathetically independent allodynia by sensitizing the central nociceptive neurons in the spinal trigeminal nucleus.
REFERENCES
- 1
Liveing E.
On Megrim, Sick Headache and Some Allied Disorders: A Contribution to the Pathology of Nerve Storms.
London
:
Churchill
; 1873.
- 2
Sluder G.
The role of the sphenopalatine ganglion in nasal headaches.
N Y State J Med. 1908; 27: 8-13.
- 3
Waldman SD.
Sphenopalatine ganglion block—80 years later.
Reg Anesth. 1993; 18: 274-276.
- 4
Diamond S,
Dalessio DJ.
The Practicing Physicians Approach to Headaches. 3rd ed.
Baltimore
,
Md
: Williams & Wilkins; 1982.
- 5
Dalessio DJ.
The major neuralgias, postinfections neuritis, intractable pain, and atypical facial pain. In: DJ Dalessio, ed. Wolff's Headache.
New York
: Oxford Press; 1980: 247-248.
- 6
Kudrow L.
Cluster Headache: Mechanism and Management.
London
: Oxford Press; 1980.
- 7
Waldman SD.
The role of neural blockade in the management of common pain syndromes. In: RS Weiner, ed. Innovations in Pain Management. Vol. 10.
Orlando
,
Fla
: Deutch Press; 1990: 4-14.
- 8
Reutens DC,
Fatovich DM,
Stewart-Wynne EG,
Prentice DA.
Is intravenous lidocaine clinically effective in acute migraine
Cephalalgia. 1991; 11: 245-247.
- 9
Kudrow L,
Kudrow DB,
Sandweiss JH.
Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings.
Headache. 1995; 35: 79-82.
- 10
Maizels M,
Scott B,
Cohen W,
Chen W.
Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial [see comments].
JAMA. 1996; 276: 319-321.
- 11
Edvinsson L.
Innervation and effects of dilatory neuropeptides on cerebral vessels. New aspects.
Blood Vessels. 1991; 28: 35-45.
- 12
Goadsby PJ,
Edvinsson L.
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
Ann Neurol. 1993; 33: 48-56.
- 13
Moskowitz MA,
Macfarlane R.
Neurovascular and molecular mechanisms in migraine headaches.
Cerebrovasc Brain Metab Rev. 1993; 5: 159-177.
- 14
Drummond PD.
Scalp tenderness and sensitivity to pain in migraine and tension headache.
Headache. 1987; 27: 45-50.
- 15
Langemark M,
Olesen J.
Pericranial tenderness in tension headache. A blind, controlled study.
Cephalalgia. 1987; 7: 249-255.
- 16
Burstein R,
Yamamura H,
Malick A,
Strassman AM.
Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons.
J Neurophysiol. 1998; 79: 964-982.
- 17
Gobel H,
Weigle L,
Kropp P,
Soyka D.
Pain sensitivity and pain reactivity of pericranial muscles in migraine and tension-type headache.
Cephalalgia. 1992; 12: 142-151.
- 18
Jensen K.
Extracranial blood flow, pain and tenderness in migraine. Clinical and experimental studies.
Acta Neurol Scand Suppl. 1993; 147: 1-27.
- 19
Jensen R,
Rasmussen BK,
Pedersen B,
Olesen J.
Muscle tenderness and pressure pain thresholds in headache. A population study.
Pain. 1993; 52: 193-199.
- 20
Jensen K,
Tuxen C,
Olesen J.
Pericranial muscle tenderness and pressure-pain threshold in the temporal region during common migraine.
Pain. 1988; 35: 65-70.
- 21
Lous I,
Olesen J.
Evaluation of pericranial tenderness and oral function in patients with common migraine, muscle contraction headache and ‘combination headache’.
Pain. 1982; 12: 385-393.
- 22
Tfelt-Hansen P,
Lous I,
Olesen J.
Prevalence and significance of muscle tenderness during common migraine attacks.
Headache. 1981; 21: 49-54.
- 23
Burstein R,
Yarnitsky D,
Goor-Aryeh I, et al.
An association between migraine and cutaneous allodynia.
Ann Neurol. 2000; 47: 614-624.
- 24
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain.
Cephalalgia. 1988; 8(suppl
7): 1-96.
- 25
Parent A.
Carpenter's Human Neuroanatomy. 9th ed. Media: Williams & Wilkins; 1996.
- 26
Fruhstorfer H,
Lindblom U,
Schmidt WC.
Method for quantitative estimation of thermal thresholds in patients.
J Neurol Neurosurg Psychiatry. 1976; 39: 1071-1075.
- 27
Yarnitsky D.
Quantitative sensory testing [see comments].
Muscle Nerve. 1997; 20: 198-204.
- 28
Yarnitsky D,
Sprecher E,
Zaslansky R,
Hemli JA.
Heat pain thresholds: normative data and repeatability.
Pain. 1995; 60: 329-332.
- 29
Edvinsson L,
Uddman R.
Adrenergic, cholinergic and peptidergic nerve fibres in dura mater—involvement in headache
Cephalalgia. 1981; 1: 175-179.
- 30
Hara H,
Hamill GS,
Jacobowitz DM.
Origin of cholinergic nerve to the rat major cerebral arteries: coexistence with vasoactive intestinal polypeptide.
Brain Res Bull. 1985; 14: 179-188.
- 31
Owman C,
Hardebo JE.
Multiple transmitter amines and peptides in cerebrovascular nerves: possible links in migraine pathophysiology.
Cephalalgia. 1986; 6 (suppl
4): 49-62.
- 32
Owman C,
Hardebo JE.
Functional heterogeneity of the cerebrovascular endothelium.
Brain Behav Evol. 1988; 32: 65-75.
- 33
Suzuki N,
Haredo JE,
Kahrstrom J,
Owman C.
Selective electrical stimulation of postganglionic cerebrovascular parasympathetic nerve fibers originating from the sphenopalatine ganglion enhances cortical blood flow in the rat.
J Cereb Blood Flow Metab. 1990; 10: 383-391.
- 34
Nozaki K,
Moskowitz MA,
Maynard KI, et al.
Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries.
J Cereb Blood Flow Metab. 1993; 13: 70-79.
- 35
Goadsby PJ,
Edvinsson L.
Neuropeptide changes in a case of chronic paroxysmal hemicrania—evidence for trigemino-parasympathetic activation.
Cephalalgia. 1996; 16: 448-450.
- 36
Minami Y,
Kimura H,
Aimi Y,
Vincent SR.
Projections of nitric oxide synthase-containing fibers from the sphenopalatine ganglion to cerebral arteries in the rat.
Neuroscience. 1994; 60: 745-759.
- 37
Delepine L,
Aubineau P.
Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion.
Exp Neurol. 1997; 147: 389-400.
- 38
Juan H,
Lembeck F.
Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear.
Naunyn Schmiedebergs Arch Pharmacol. 1974; 283: 151-164.
- 39
Tanelian DL.
Cholinergic activation of a population of corneal afferent nerves.
Exp Brain Res. 1991; 86: 414-420.
- 40
Couture R,
Gupta A,
Kerouac R, et al.
Spinal actions of substance P analogues on cardiovascular responses in the rat: a structure-activity analysis.
Can J Physiol Pharmacol. 1987; 65: 412-418.
- 41
Ralevic V,
Khalil Z,
Dusting GJ,
Helme RD.
Nitric oxide and sensory nerves are involved in the vasodilator response to acetylcholine but not calcitonin gene-related peptide in rat skin microvasculature.
Br J Pharmacol. 1992; 106: 650-655.
- 42
Steen KH,
Reeh PW.
Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro.
J Neurophysiol. 1993; 70: 397-405.
- 43
Hua XY,
Back SM,
Yaksh TL.
Characterization of muscarinic receptors involved in tracheal CGRP release.
Neuroreport. 1994; 5: 2133-2136.
- 44
Roberts RG,
Stevenson JE,
Westerman RA,
Pennefather J.
Nicotinic acetylcholine receptors on capsaicin-sensitive nerves.
Neuroreport. 1995; 6: 1578-1582.
- 45
Delaunois A,
Gustin P,
Segura P, et al.
Interactions between acetylcholine and substance P effects on lung mechanics in the rabbit.
Fundam Clin Pharmacol. 1996; 10: 278-288.
- 46
Reynier-Rebuffel AM,
Callebert J,
Dimitriadou V, et al.
Carbachol induces granular cell exocytosis and serotonin release in rabbit cerebral arteries.
Am J Physiol. 1992; 262: R105-R111.
- 47
Couture R,
Kerouac R.
Plasma protein extravasation induced by mammalian tachykinins in rat skin: influence of anaesthetic agents and an acetylcholine antagonist.
Br J Pharmacol. 1987; 91: 265-273.
- 48
Khalil Z,
Marley PD,
Livett BG.
Effect of substance P on nicotine-induced desensitization of cultured bovine adrenal chromaffin cells: possible receptor subtypes.
Brain Res. 1988; 459: 282-288.
- 49
Krabbe AA,
Olesen J.
Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms.
Pain. 1980; 8: 253-259.
- 50
Ottosson AL,
Jansen I,
Langemark M, et al.
Histamine receptors in the isolated human middle meningeal artery. A comparison with cerebral and temporal arteries.
Cephalalgia. 1991; 11: 183-188.
- 51
Toda N.
Mechanism underlying responses to histamine of isolated monkey and human cerebral arteries.
Am J Physiol. 1990; 258: H311-H317.
- 52
Iadecola C,
Pelligrino DA,
Moskowitz MA,
Lassen NA.
Nitric oxide synthase inhibition and cerebrovascular regulation.
J Cereb Blood Flow Metab. 1994; 14: 175-192.
- 53
Rand MJ.
Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission.
Clin Exp Pharmacol Physiol. 1992; 19: 147-169.
- 54
Luscher TF,
Vanhoutte PM.
The Endothelium: Modulator of Cardiovascular Functions.
Ann Arbor
,
Mich
: CRC Press; 1990.
- 55
Salvemini D,
Radziszewski W,
Mollace V, et al.
Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation.
Eur J Pharmacol. 1991; 199: 15-18.
- 56
Olesen J,
Iversen HK,
Thomsen LL.
Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain.
Neuroreport. 1993; 4: 1027-1030.
- 57
Suzuki N,
Hardebo JE,
Owman C.
Origins and pathways of choline acetyltransferase-positive parasympathetic nerve fibers to cerebral vessels in rat.
J Cereb Blood Flow Metab. 1990; 10: 399-408.
- 58
Simone DA,
Sorkin LS,
Oh U, et al.
Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons.
J Neurophysiol. 1991; 66: 228-246.
- 59
Torebjork HE,
Lundberg LE,
LaMotte RH.
Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans.
J Physiol (Lond). 1992; 448: 765-780.
- 60
Ren K,
Dubner R.
NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw.
Neurosci Lett. 1993; 163: 22-26.
- 61
Koltzenburg M,
Torebjork HE,
Wahren LK.
Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain.
Brain. 1994; 117: 579-591.
- 62
Woolf CJ,
Shortland P,
Reynolds M, et al.
Reorganization of central terminals of myelinated primary afferents in the rat dorsal horn following peripheral axotomy.
J Comp Neurol. 1995; 360: 121-134.
- 63
Magerl W,
Wilk SH,
Treede RD.
Secondary hyperalgesia and perceptual wind-up following intradermal injection of capsaicin in humans.
Pain. 1998; 74: 257-268.
- 64
Yamamura H,
Malick A,
Chamberlin NL,
Burstein R.
Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine.
J Neurophysiol. 1999; 81: 479-493.